The George Institute For Global Health
Global
United Kingdom
India
China
Australia

News and Events

The frequency of industry-sponsored trials in emerging countries is increasing at a rapid rate. In China alone, the number doubled between 2005 and 2010. It is anticipated that emerging markets will soon represent the largest market for global pharmaceutical sales.

Media release: 
04/09/2013

A study of more than 153,000 people across 17 countries has found that close to half of those with hypertension are unaware they have the condition, which is the leading cause of preventable mortality and morbidity globally.

Media release: 
04/09/2013

Indian patients were much more likely to take preventive medicines if they are combined in one pill, according to the first trial of the polypill in patients with cardiovascular disease.

Registration for Big Change: sustainable healthcare for the 21st century, is now open. This event will highlight the challenges to providing effective healthcare in the 21st century, and identify affordable, innovative ways to tackle these challenges.

Professor Stephen MacMahon, Principal Director and a founder of The George Institute for Global Health has been awarded the RT Hall Prize, the most prestigious award of the Cardiac Society of Australia and New Zealand (CSANZ).

Healthcare workers in the UK and around the world are rapidly adopting new information technology tools to assist them in their work. These range from vast national networks such as the UK’s Summary Care Record service to personalised mobile applications such as the “Epocrates” medication reference “app”.

Australia’s most popular food-scanning app, FoodSwitch, has been recognised as one of the world’s top 100 innovative initiatives, selected from entries spanning more than 79 countries.

In a recent report published in the Lancet on the global dimensions of kidney disease, Professor Vivek Jha, Executive Director, George Institute India and other researchers, reported that diabetes is a major cause of this chronic illness.

Media release: 
29/05/2013

A landmark study has revealed a new way to treat intracerebral haemorrhage which stands to help millions of people worldwide. The George Institute for Global Health study found that intensive blood pressure lowering in patients with intracerebral haemorrhage, the most serious type of stroke, reduced the risk of major disability and improved chances of recovery by as much as 20 per cent.

At the invitation of the Indian Institute of Science (IISC), in Bangalore, Professor MacMahon, Principal Director of The George Institute for Global Health, addressed the faculty and students of the Biological Sciences Department at the IISc campus on 17 May 2013.

Pages